Woodline Partners LP Roivant Sciences Ltd. Transaction History
Woodline Partners LP
- $9.97 Billion
- Q2 2024
A detailed history of Woodline Partners LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Woodline Partners LP holds 8,000,939 shares of ROIV stock, worth $93.5 Million. This represents 0.85% of its overall portfolio holdings.
Number of Shares
8,000,939
Previous 11,172,306
28.39%
Holding current value
$93.5 Million
Previous $118 Million
28.18%
% of portfolio
0.85%
Previous 1.12%
Shares
8 transactions
Others Institutions Holding ROIV
# of Institutions
314Shares Held
496MCall Options Held
991KPut Options Held
1.15M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$834 Million6.97% of portfolio
-
Viking Global Investors LP69.2MShares$808 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$779 Million72.99% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$413 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.3MShares$343 Million0.02% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.23B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...